Trimethylamine-N-oxide-induced folding of α-synuclein  by Uversky, Vladimir N. et al.
Trimethylamine-N-oxide-induced folding of K-synuclein
Vladimir N. Uverskya;b, Jie Lia, Anthony L. Finka;*
aDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064, USA
bInstitute for Biological Instrumentation, Russian Academy of Sciences, Pushchino, Moscow Region 142290, Russia
Received 24 October 2001; accepted 30 October 2001
First published online 8 November 2001
Edited by Jesus Avila
Abstract The effect of the natural osmolyte trimethylamine-N-
oxide (TMAO) on the structural properties and fibril formation
of the natively unfolded protein human K-synuclein was studied
using several physico-chemical methods. TMAO induced folding
of K-synuclein: at moderate concentrations, a partially folded
intermediate with enhanced propensity for fibrillation accumu-
lated; at higher concentrations, K-synuclein was tightly folded
and underwent self-association to form oligomers. The latter
conformation was significantly helical and probably represents
the physiologically folded form of the protein. ß 2001 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
K-Synuclein is a small (14 kDa), highly conserved presyn-
aptic protein that is abundant in various regions of the brain
[1^3]. Structurally, puri¢ed K-synuclein belongs to the family
of natively unfolded proteins [4^6], which are characterized by
a unique combination of low overall hydrophobicity and large
net charge [7]. Deposition of aggregated forms of K-synuclein
in neuronal or glial cytoplasm is a pathological hallmark of
several neurodegenerative diseases, including Parkinson’s dis-
ease, dementia with Lewy bodies, Lewy body variant of Alz-
heimer’s disease, and multiple system atrophy [8,9]. In vitro,
the protein forms ¢brils with morphologies and staining char-
acteristics similar to those extracted from disease-a¡ected
brain [10^15]. The kinetics of ¢brillation are consistent with
a nucleation-dependent mechanism [11,16], in which the crit-
ical early stage of the structural transformation involves a
partially folded intermediate [5].
The function of K-synuclein is unknown. It is generally
accepted that the biological functions of proteins are prede-
termined by their 3D structures. Hence, the existence of na-
tively unfolded proteins raises the question of the structural
basis of their function. It has been suggested that the large
£exibility of natively unfolded proteins allows them to interact
e⁄ciently with several di¡erent targets [17,18]. Thus, natively
unfolded proteins may be signi¢cantly folded in their normal
cellular milieu due to binding to speci¢c targets and ligands.
Recently it has been demonstrated that the naturally occur-
ring osmolyte, trimethylamine-N-oxide (TMAO), can cause
thermodynamically unstable proteins to fold, and regain
high functional activity [19,20]. Osmolytes may fold unstruc-
tured proteins due to the osmophobic e¡ect, a solvophobic
thermodynamic force, arising from the unfavorable interac-
tion between the osmolyte and the peptide backbone [21].
2. Materials and methods
2.1. Expression and puri¢cation of recombinant K-synuclein
The expression (in Escherichia coli) and puri¢cation of K-synuclein
were as described previously [5].
2.2. Materials
Thio£avin T (TFT), TMAO and 1-anilinonaphthalene-8-sulfonic
acid (ANS) were obtained from Sigma, St. Louis, MO, USA. All
other chemicals were of analytical grade from Fisher Chemicals.
2.3. Circular dichroism measurements
CD spectra were obtained with an AVIV 60DS spectrophotometer
(Lakewood, NJ, USA) using an K-synuclein concentration of 70 WM.
Near-UV CD spectra were recorded in a 1.0 cm pathlength cell, far-
UV CD with a 0.01 cm pathlength cell. CD spectra of the appropriate
bu¡ers were recorded and subtracted from the protein spectra.
2.4. Fluorescence measurements
Fluorescence measurements were made in semimicro quartz cu-
vettes (Hellma) with a 1 cm excitation light path using a FluoroMax-
2 spectro£uorometer (Instruments S.A., Inc., USA). ANS emission
spectra were recorded with excitation at 350 nm. ANS and protein
concentrations were 15 and 5 WM, respectively. All data were pro-
cessed using DataMax/GRAMS software. Time courses of changes in
ANS £uorescence intensity were analyzed at 470 nm with excitation at
350 nm.
2.5. Acrylamide quenching
Acrylamide quenching studies of the intrinsic £uorescence of K-
synuclein were performed by adding aliquots from a stock solution
of the quencher into a cuvette containing the protein solution. Fluo-
rescence intensities were corrected for dilution e¡ects. Fluorescence
quenching data were analyzed as described in [5], using the general
form of the Stern^Volmer equation [22].
2.6. Small angle X-ray scattering (SAXS) experiments
SAXS measurements were made using Beam Line 4-2 at Stanford
Synchrotron Radiation Laboratory [23,24]. Experimental conditions
and protocol were as described in [5]. The radius of gyration (Rg) was
calculated according to the Guinier approximation [25].
2.7. Fibril formation assay
Assay solutions contained 15 WM TFT and protein at a concentra-
tion of 70 WM (1.0 mg/ml) in 20 mM Tris^HCl, 0.1 M NaCl, pH 7.5,
and the desired TMAO concentration. A volume of 100 Wl of the
mixture was pipetted into a well of a 96-well plate (white plastic, clear
bottom) and a 1/8Q-diameter Te£on sphere (McMaster-Carr, Los An-
geles, CA, USA) was added. Each sample was run in triplicate or
quadruplicate. The plate was loaded into a £uorescence plate reader
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(Fluoroskan Ascent) and incubated at 37‡C with shaking at 300^600
rpm with a shaking diameter of 1 mm. The £uorescence was measured
at 30 min intervals with excitation at 450 nm and emission at 485 nm,
and curve-¢t as described in [26].
3. Results
3.1. TMAO induces biphasic secondary structure formation
transitions in K-synuclein
In order to investigate the e¡ect of TMAO on the confor-
mation of human K-synuclein, several structural approaches
were used. At pH 7.5 and at 20‡C, the far-UV CD spectrum
of recombinant human K-synuclein in the absence of TMAO
shows a spectrum typical of an unfolded protein. As the con-
centration of TMAO is increased, changes are observed cor-
responding to formation of secondary structure, Fig. 1A. At
high TMAO concentrations (s 3 M), K-synuclein showed a
far-UV CD spectrum typical of a well-folded protein.
Fig. 1B represents the TMAO-dependencies of [a]222 and
[a]200. The K-synuclein folding is described by two successive
sigmoidal curves separated by a pronounced plateau, with
V30% secondary structure being formed in the ¢rst step.
Interestingly, the shape and intensity of the far-UV CD spec-
tra measured in the vicinity of 2 M TMAO are close to those
reported for the previously observed partially folded inter-
mediate [5,27]. Thus, TMAO initially induces formation of
the intermediate (Cm = 1.4 þ 0.1 M), which subsequently trans-
forms into a species with well-organized secondary structure
(Cm = 2.3 þ 0.1 M).
3.2. TMAO-induced changes in ANS binding
Changes in ANS £uorescence are characteristic of the in-
teraction of this dye with solvent-exposed hydrophobic surfa-
ces of partially folded proteins [28]. Fig. 2A shows that the
addition of TMAO to K-synuclein in the presence of ANS
leads to dramatic changes in the ANS £uorescence spectrum;
a signi¢cant increase in the £uorescence intensity and a pro-
nounced (V30 nm) blue shift in Vmax. Interestingly, the ANS
spectrum for K-synuclein in the presence of 1.8 M TMAO is
close to that reported for partially folded K-synuclein [5,27].
However, a further increase in TMAO concentration is ac-
companied by an additional increase in the ANS £uorescence
intensity (Fig. 2A).
In order to investigate the underlying molecular mechanism
of TMAO-induced folding of K-synuclein, we looked at the
time course of the increase in ANS £uorescence intensity in
solutions containing 1 and 5 WM of the protein (Fig. 2B).
Interestingly, for both protein concentrations in the presence
of 1.8 M TMAO, the conformational changes occurred rap-
idly, within the dead time of the manual mixing experiment
(V5 s). This illustrates that under the conditions studied, the
osmolyte-induced partial folding of K-synuclein is an intra-
molecular process and is not accompanied by association of
the partially folded molecules.
However, in the solutions with higher TMAO concentration
(3.5 M), the kinetics are biphasic and di¡erent for di¡erent
protein concentrations. Fig. 2B illustrates that a V25% in-
crease in the ANS £uorescence intensity occurs within the
dead time of the experiments, independent of the K-synuclein
concentration. Subsequent slower changes are protein concen-
Fig. 1. E¡ect of TMAO on the structural properties of human K-
synuclein. A: Far-UV CD spectra as a function of TMAO concen-
tration. The spectrum of the partially folded intermediate induced in
K-synuclein at pH 3.0 is shown for comparison (circles). B: TMAO-
dependent conformational changes: [a]222 (open circles) and [a]200
(black circles). Measurements were carried out at 20‡C. Protein con-
centration was 70 WM.
Fig. 2. E¡ect of TMAO on ANS binding to K-synuclein. A: ANS
spectra as a function of TMAO concentration. B: Kinetics of ANS
spectral changes induced by TMAO (1.8 M (curves 1 and 2) and
3.5 M (curves 3 and 4). Measurements were carried out for di¡erent
protein concentrations: 1 WM (curves 1 and 3) and 5 WM (curves 2
and 4). The ANS £uorescence intensity in the absence of TMAO is
shown as straight line.
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tration-dependent, with rate constants of 3.7 þ 0.2U1034 s31
and 1.1 þ 0.1U1033 s31 for 1 and 5 WM of the protein, re-
spectively, indicating that the slower kinetic phase re£ects as-
sociation of K-synuclein. Thus, in the presence of 3.5 M
TMAO, K-synuclein folds rapidly into the partially folded
conformation, which then associates in a protein concentra-
tion-dependent manner.
3.3. TMAO-induced changes in the environment of tyrosine
residues
Further evidence for TMAO-induced structural changes in
K-synuclein are shown in Fig. 3. Information on the relative
solvent exposure of tyrosine residues (there are no trypto-
phans in K-synuclein) can be obtained from analysis of the
e¡ect of quencher molecules such as acrylamide [22]. Fig. 3A
shows the Stern^Volmer plots for K-synuclein as a function of
TMAO. The upward curvature indicates the presence of both
dynamic and static quenching [22]. In the absence of osmolyte
KSV = 15.9 þ 0.2 M31, which is somewhat smaller than the
value for free L-tyrosine (KSV = 21.1 þ 0.2 M31) [32]. In the
presence of 1.8 M TMAO, KSV decreases to 13.1 þ 0.1 M31,
whereas in 3.5 M TMAO, KSV decreases to 8.5 þ 0.2 M31.
This means that the tyrosine residues of natively unfolded
K-synuclein are partially protected from the quencher mole-
cules and the degree of protection increases as the TMAO
concentration increases. The value of KSV of K-synuclein in
the presence of 3.5 M TMAO is representative of typical
folded globular proteins.
Fig. 3B represents the near-UV CD spectra of K-synuclein
measured at di¡erent TMAO concentrations. In the absence
of osmolyte or in the presence of 1.8 M TMAO, there is an
essentially £at spectrum. This indicates that natively unfolded
or partially folded K-synuclein has no rigid tertiary structure.
However, in the presence of 3.5 M TMAO, a very prominent
band in the vicinity of 275 nm appears. Thus, self-association
of the partially folded intermediate is accompanied by the
appearance of signi¢cant tertiary structure.
3.4. SAXS shows oligomers at high TMAO
SAXS provides information about the packing density,
shape and dimensions of biopolymers in solution [25]. Guinier
analysis of the scattering data shows that the addition 3.5 M
TMAO leads to a signi¢cant increase in Rg for K-synuclein,
from 41.1 þ 1.2 to 64.9 þ 0.3 Aî (Fig. 4A). We attribute the
large increase in Rg induced by 3.5 M TMAO to self-associ-
ation. Analysis of the SAXS forward-scattering intensity val-
ues, I(0), show that in the presence of 3.5 M TMAO, the I(0)
value for K-synuclein is V10-fold larger than that determined
for the protein in the absence of osmolyte (0.3855 þ 0.0035 vs.
0.03985 þ 0.0012, respectively). Thus, K-synuclein is mono-
meric in the absence of TMAO, but associates to form olig-
omers (probably decamers) at high concentrations of TMAO.
Analysis of the X-ray scattering in the form of a Kratky
plot shows that in aqueous solution, as expected, K-synuclein
does not have a well-developed globular structure (Fig. 4B; cf.
[5,13]). However, the pro¢le of the Kratky plot in the presence
of 3.5 M TMAO shows a pronounced maximum at low an-
gles, which indicates that the subunits in the oligomer are
globular (i.e. tightly folded). Analogous behavior has been
observed previously during the association of partially folded
intermediates of staphylococcal nuclease [29,30].
Fig. 3. A: Stern^Volmer plots for K-synuclein in the absence (P) or
presence of 1.8 M (E) or 3.5 M TMAO (a). Fluorescence quench-
ing by acrylamide. B: Near-UV CD spectra for K-synuclein in the
presence of 0, 1.8 or 3.5 M TMAO. Measurements were carried out
at 20‡C.
Fig. 4. Guinier (A) and Kratky plot (B) representation of the results
of SAXS analysis of K-synuclein: 1: without TMAO; 2: 3.5 M
TMAO. Measurements were carried out at 23‡C. Protein concentra-
tion was 210 WM.
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3.5. TMAO modulates ¢brillation of K-synuclein
TFT is a £uorescent dye that interacts with amyloid ¢brils
leading to an increase in the £uorescence intensity in the vi-
cinity of 480 nm [31,32]. Fig. 5 shows that TMAO a¡ected the
kinetics of K-synuclein ¢brillation in a concentration-depen-
dent fashion. The rate of ¢bril formation was substantially
enhanced in the presence of 1 and 2 M TMAO, whereas it
was essentially completely inhibited in solutions of 3 M
TMAO. The acceleration of ¢bril formation in the presence
of low concentrations of TMAO is due to the osmolyte-in-
duced stabilization of the partially folded K-synuclein inter-
mediate, which was previously shown to be a critical step in
the early stage of ¢brillogenesis [5,13,27]. The fact that in the
presence of 3.5 M TMAO, K-synuclein self-associates to form
well-folded oligomers with globular structure, yet does not
¢brillate, suggests that these oligomers are not on the ¢brilla-
tion pathway, and are quite stable. This also may explain the
lower TFT signal observed for this protein in 2 M TMAO
solutions (see Fig. 5).
4. Discussion
Our results demonstrate that TMAO causes natively un-
folded K-synuclein to fold in a biphasic manner. Moderate
TMAO concentrations (between 1 and 2 M) result in a parti-
ally folded intermediate that possesses structural properties
previously described for this protein at high temperatures,
low pH [5], and in the presence of certain metal cations [27]
or pesticides [33]. The present results indicate that the osmo-
phobic e¡ect must be added to the previously described fac-
tors that induce the transformation of natively unfolded K-
synuclein into the partially folded intermediate. Higher con-
centrations of TMAO lead to formation of an oligomer, prob-
ably a decamer, based on the SAXS data.
The partially folded conformation is not only stabilized
under conditions of moderate osmolyte concentrations, but
is also transiently populated in the kinetic pathway of oligo-
mer formation at high TMAO concentration. Thus, depend-
ing on the conditions, the intermediate may self-associate
leading to ¢brils, amorphous aggregates or soluble globular
oligomers. Furthermore, under all the situations in which the
intermediate is populated, K-synuclein ¢brillates signi¢cantly
faster than in control experiments, consistent with the inter-
mediate being a critical species in the ¢brillation pathway.
Interestingly, however, the addition of high osmolyte concen-
trations transforms the protein into oligomers in which the
subunits are folded, and which do not ¢brillate. It is not clear
if it is the globular structure, or the strong intermolecular
interactions between individual molecules, that prevents ¢bril-
lation in the oligomers.
The CD spectrum of K-synuclein in high TMAO concen-
tration reveals signi¢cant helical structure. This conformation
is thus likely to represent the conformation of K-synuclein
when associated with its intracellular partners. The fact that
this form of the protein does not ¢brillate may also be sig-
ni¢cant with respect to the in vivo situation.
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